Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seliger

Showing results (261-270 of 304) with videos related to

Pageof 31
Sort By:
Cancer Research|March 17, 2006
Common cancer biomarkersChristopher F Basil, Yingdong Zhao, Katia Zavaglia, et al.
Oncoimmunology|March 28, 2017
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysisWouter Hendrickx, Ines Simeone, Samreen Anjum, et al.
Nature Communications|May 20, 2025
HIV status alters immune cell infiltration and activation profile in women with breast cancerMarcus Bauer, Pablo Santos, Andreas Wilfer, et al.
Journal of Translational Medicine|May 13, 2020
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutatedMuna Al Hashmi, Konduru S Sastry, Lee Silcock, et al.
Transplantation|February 9, 2012
Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantationFriedrich Stölzel, Karl Hackmann, Friederike Kuithan, et al.
Frontiers in Immunology|January 11, 2020
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome DisplayStina L Wickström, Tanja Lövgren, Michael Volkmar, et al.
International Journal of Cancer|December 11, 2023
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanismsLisa Dinter, Paula C Karitzky, Alexander Schulz, et al.
Cancer Research Communications|October 28, 2022
Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast CancerMargaret L Axelrod, Yu Wang, Yaomin Xu, et al.
JCI Insight|July 21, 2017
Multiparametric immune profiling in HPV- oral squamous cell cancerZipei Feng, Daniel Bethmann, Matthias Kappler, et al.
Breast Cancer Research : BCR|November 26, 2024
Immune landscape of the tumour microenvironment in Ethiopian breast cancer patientsMeron Yohannes, Zelalem Desalegn, Marcus Bauer, et al.
Pageof 31

Showing results (261-270 of 304) with videos related to

Sort By:
Pageof 31
Cancer Research|March 17, 2006
Common cancer biomarkersChristopher F Basil, Yingdong Zhao, Katia Zavaglia, et al.
Oncoimmunology|March 28, 2017
Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysisWouter Hendrickx, Ines Simeone, Samreen Anjum, et al.
Nature Communications|May 20, 2025
HIV status alters immune cell infiltration and activation profile in women with breast cancerMarcus Bauer, Pablo Santos, Andreas Wilfer, et al.
Journal of Translational Medicine|May 13, 2020
Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutatedMuna Al Hashmi, Konduru S Sastry, Lee Silcock, et al.
Transplantation|February 9, 2012
Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantationFriedrich Stölzel, Karl Hackmann, Friederike Kuithan, et al.
Frontiers in Immunology|January 11, 2020
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome DisplayStina L Wickström, Tanja Lövgren, Michael Volkmar, et al.
International Journal of Cancer|December 11, 2023
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanismsLisa Dinter, Paula C Karitzky, Alexander Schulz, et al.
Cancer Research Communications|October 28, 2022
Peripheral Blood Monocyte Abundance Predicts Outcomes in Patients with Breast CancerMargaret L Axelrod, Yu Wang, Yaomin Xu, et al.
JCI Insight|July 21, 2017
Multiparametric immune profiling in HPV- oral squamous cell cancerZipei Feng, Daniel Bethmann, Matthias Kappler, et al.
Breast Cancer Research : BCR|November 26, 2024
Immune landscape of the tumour microenvironment in Ethiopian breast cancer patientsMeron Yohannes, Zelalem Desalegn, Marcus Bauer, et al.
Pageof 31